Evidence map›Paper›PMID 34065007›Full record

ArticleCancers2021

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.

Ilenia Iaia, Loretta Gammaitoni, Giulia Cattaneo, Lidia Giraudo, Chiara Donini, Erika Fiorino, Luca Primo, Fabrizio Carnevale-Schianca, Massimo Aglietta, Alberto Puliafito and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ilenia IaiaCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0001-9698-1402
Loretta GammaitoniCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Giulia CattaneoCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Lidia GiraudoCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Chiara DoniniCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0003-1988-9762
Erika FiorinoCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0002-8662-9525
Luca PrimoCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Fabrizio Carnevale-SchiancaCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Massimo AgliettaCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Alberto PuliafitoCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Dario SangioloCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Candiolo Cancer Institute · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG-2017 n. 20259Associazione Italiana per la Ricerca sul Cancro IG-23211Fondazione del Piemonte per l'Oncologia (FPO-IRCCS) Young Investigator Grant 2020FPRC ONLUS 5x1000, Ministero della Salute 2015 Cancer ImGenMinistero della Salute Ricerca Corrente 2020Università degli Studi di Torino Fondo Ricerca Locale 2017Università degli Studi di Torino Fondo Ricerca Locale 2019 PULA_RILO_19_01
6 · The paper itself

Abstract

Cancer adoptive cell therapy (ACT) with HLA-independent tumor killer lymphocytes is a promising approach, with intrinsic features potentially addressing crucial tumor-escape mechanisms of checkpoint inhibitors. Cytokine-induced Killer (CIK) and Natural Killer (NK) lymphocytes share similar tumor-killing mechanisms, with preclinical evidence of intense activity against multiple solid tumors and currently testing in clinical studies. To improve the effective clinical translation of such ACT approaches, several fundamental questions still need to be addressed within appropriate preclinical contexts, capable of overcoming limitations imposed by most traditional two-dimensional assays. Here, we developed a novel experimental approach to explore, dissect, and visualize the interactions of CIK and NK lymphocytes with melanoma tumors in vitro in 3D. Primary melanoma cells were assembled into small tumors that were dispersed in a 3D matrix and challenged with patient-derived CIK or the NK-92 cell line. By means of imaging-based methods, we reported, visualized, and quantitatively measured the recruitment of CIK and NK on the 3D targets, their infiltration, and cytotoxic activity. Our results support the effective tumor recruitment and tumor infiltration by CIK and NK. Such features appeared dependent on the specific geometric aspects of the environment but can be explained in terms of directional migration toward the tumor, without invoking major feedback components. Overall, our 3D platform allows us to monitor the processes of tumor recruitment, infiltration, and killing by means of live measurements, revealing important kinetic aspects of ACT with CIK and NK against melanoma.

Indexed as

3D modelscell therapyimagingmelanoma

Identifiers

PMID34065007
PMCPMC8151151
OpenAlexW3160627865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.